---
title: "Evoq Remedies Ltd (543500) — Share Price, Financials & Analysis"
symbol: "543500"
company: "Evoq Remedies Ltd"
canonical: "https://tapetide.com/stocks/543500"
isin: "INE0JVD01011"
nse_symbol: "EVOQREMEDIESLTD"
bse_code: "543500"
sector: "Commercial Services"
industry: "Trading & Distributors"
market_cap_cr: 3.8
generated_at: "2026-09-13T19:17:27.720Z"
---

# Evoq Remedies Ltd (543500)

Canonical page: https://tapetide.com/stocks/543500

## Company

- **NSE Symbol:** EVOQREMEDIESLTD
- **BSE Code:** 543500
- **ISIN:** INE0JVD01011
- **Sector:** Commercial Services
- **Industry:** Trading & Distributors
- **Macro Sector:** Services
- **Stock Type:** EQUITY
- **Listed Since:** 2022-03-30
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** evoqremedies.com

## About

Incorporated in 2010, EVOQ Remedies Ltd is in the pharmaceutical business.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:45:37.572958Z.

- **Market Cap:** ₹3.8 Cr
- **Classification:** SME
- **P/E (reported):** -15.4
- **EPS (reported):** ₹0.18
- **Book Value:** ₹17.79
- **Price to Book:** 0.09
- **Dividend Yield:** 0%
- **ROE:** 0.2%
- **ROCE:** 0.29%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹25.51 Cr
- **Net Income:** ₹-0.24 Cr
- **EBITDA:** ₹-1.45 Cr
- **52-Week High:** ₹6.11
- **52-Week Low:** ₹1.51
- **RSI (14):** 30.61

## Tapetide Score

- **Score:** 48 / 100
- **Score date:** 2026-09-04
- **Archetype:** No Dominant Pattern
- **What it means:** The three pillars do not combine into a recognisable pattern. Read them individually rather than looking for one story — the lack of a pattern is itself the finding.
- **Pillar profile:** Quality: Average · Valuation: Fair · Momentum: Falling
- **Percentile:** 39.4 (of 4473 scored stocks)
- **Confidence:** 84%
- **Data coverage:** 67%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 63.31 | 9% |
| growth | 97.61 | 9% |
| momentum | 5.62 | 12% |
| ownership | 33.7 | 24% |
| quality | 51.85 | 22% |
| valuation | 56.27 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Stock is trading at 0.08 times its book value
- Debtor days have improved from 160 to 55.1 days.

### Weaknesses

- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -11.2%
- Promoter holding is low: 0.02%
- Company has a low return on equity of 0.29% over last 3 years.
- Contingent liabilities of Rs.6.55 Cr.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | -374.81% | -236.09% | — |
| ebitda margin growth | -533.6% | -155.25% | -162.16% |
| net income growth | -340% | -148% | -121.82% |
| revenue growth | 79.65% | 8% | 21% |
| roce | -88.02% | -96.85% | 29.29% |
| roe | -88.83% | 2.84% | -99.79% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 2.76 | 4.93 | 11.85 | 15.79 | 4.6 | 3.9 | 0.15 | 0 | 11.76 | 25.51 | 0 |
| Expenses | 1.71 | 4.2 | 11.12 | 15.48 | 8.64 | 3.83 | 1.87 | 1.63 | 12.36 | 26.46 | 0.5 |
| Operating Profit | 1.05 | 0.73 | 0.73 | 0.31 | -4.04 | 0.07 | -1.72 | -1.63 | -0.6 | -0.95 | -0.5 |
| OPM % | 38.04 | 14.81 | 6.16 | 1.96 | -87.83 | 1.79 | -1146.67 | — | -5.1 | -3.72 | — |
| Other Income | 0 | 0 | 0 | 0 | 6.02 | 0 | 2.26 | 0.01 | 2.4 | 1.06 | 0.19 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0.03 | 0.02 |
| Profit before tax | 1.05 | 0.73 | 0.73 | 0.31 | 1.98 | 0.07 | 0.54 | -1.62 | 1.76 | 0.08 | -0.33 |
| Tax % | 22.86 | 0 | 50.68 | 0 | 33.84 | 28.57 | 29.63 | 0 | 2.27 | 25 | -12.12 |
| Net Profit | 0.81 | 0.73 | 0.36 | 0.31 | 1.31 | 0.05 | 0.38 | -1.62 | 1.71 | 0.05 | -0.29 |
| EPS in Rs | 810 | 730 | 0.26 | 0.23 | 0.96 | 0.04 | 0.28 | -0.65 | 0.69 | 0.02 | -0.12 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 3.25 | 9.07 | 10.02 | 16.78 | 20.39 | 4.05 | 11.76 | 25.51 |
| Expenses | 3.23 | 9.07 | 9.07 | 15.32 | 24.12 | 5.69 | 13.99 | 26.96 |
| Operating Profit | 0.02 | 0 | 0.95 | 1.46 | -3.73 | -1.64 | -2.23 | -1.45 |
| OPM % | 0.62 | 0 | 9.48 | 8.7 | -18.29 | -40.49 | -18.96 | -5.68 |
| Other Income | 0 | 0 | 0 | 0 | 6.02 | 2.26 | 2.41 | 1.25 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.05 | 0.05 |
| Profit before tax | 0.02 | 0 | 0.95 | 1.46 | 2.29 | 0.61 | 0.13 | -0.25 |
| Tax % | 0 | — | 25.26 | 25.34 | 29.26 | 26.23 | 30.77 | -4 |
| Net Profit | 0.01 | 0 | 0.72 | 1.09 | 1.62 | 0.45 | 0.09 | -0.24 |
| EPS in Rs | 10 | 0 | 720 | 0.8 | 1.19 | 0.33 | 0.04 | -0.1 |
| Dividend Payout % | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.01 | 0.01 | 0.01 | 13.6 | 13.6 | 13.6 | 24.9 | 24.9 |
| Reserves | 0.01 | 0.01 | 0.73 | 9.57 | 11.19 | 11.64 | 19.64 | 19.4 |
| Borrowings | 0 | 0.01 | 0 | 8.16 | 9.58 | 4.24 | 0 | 0.07 |
| Other Liabilities | 2.12 | 5.62 | 7.3 | 2 | 0.53 | 7.39 | 5.47 | 7.57 |
| Total Liabilities | 2.14 | 5.65 | 8.04 | 33.33 | 34.9 | 36.87 | 50.01 | 51.94 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.22 | 0.17 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 2.14 | 5.65 | 8.04 | 33.33 | 34.89 | 36.86 | 49.79 | 51.77 |
| Total Assets | 2.14 | 5.65 | 8.04 | 33.33 | 34.9 | 36.87 | 50.01 | 51.94 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0.01 | -0.02 | 0.03 | -26.43 | -4.35 | 5.32 | -14.62 | -0.28 |
| Cash from Investing Activity | 0 | 0 | 0 | 0 | -0.01 | -0.01 | -0.26 | 0 |
| Cash from Financing Activity | 0 | 0 | 0 | 29.49 | 1.42 | -5.34 | 14.97 | 0.07 |
| Net Cash Flow | 0.01 | -0.02 | 0.03 | 3.06 | -2.94 | -0.03 | 0.09 | -0.21 |
| Free Cash Flow | 0.01 | -0.02 | 0.03 | -26.43 | -4.36 | 5.31 | -14.88 | -0.28 |
| CFO/OP | 50 | — | 3 | -1785 | 99 | -334 | 654 | 19 |

### Ratios

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 138.14 | 189.94 | 249.16 | 552.5 | 308.25 | 156.81 | 267.54 | 55.09 |
| Inventory Days | 3.39 | 2.42 | 6.97 | 20.66 | 38.33 | 732.34 | 61.9 | 23.92 |
| Days Payable | 239.57 | 226.66 | 315.25 | 32.05 | -10.2 | 767.44 | 97.59 | 10.89 |
| Cash Conversion Cycle | -98.04 | -34.3 | -59.11 | 541.11 | 356.78 | 121.72 | 231.85 | 68.12 |
| Working Capital Days | 1.12 | 1.21 | 26.23 | 436.56 | 440.9 | 2263 | 1369.06 | 631.27 |
| ROCE % | — | 0 | 246.75 | 9.11 | 6.97 | 1.91 | 0.35 | -0.56 |

## Shareholding Pattern

### Quarterly

| Category | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 73.53% | 73.53% | 73.53% | 73.53% | 20.53% | 11.21% | 11.21% | 11.21% | 11.21% | 0.02% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 23.06% | 24.56% | 25.21% | 24.91% | 73.38% | 85.57% | 85.75% | 84.74% | 83.89% | 94.57% |
| Others | 3.41% | 1.91% | 1.26% | 1.56% | 6.09% | 3.21% | 3.04% | 4.05% | 4.9% | 5.41% |
| No. of Shareholders | 827 | 727 | 707 | 727 | 1672 | 1588 | 1577 | 1723 | 1679 | 1655 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 5 / 2 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1.58 | Sell |
| EMA (10) | 1.58 | Sell |
| SMA (20) | 1.66 | Sell |
| EMA (20) | 1.66 | Sell |
| SMA (50) | 1.87 | Sell |
| EMA (50) | 1.91 | Sell |
| SMA (100) | 2.51 | Sell |
| EMA (100) | 2.28 | Sell |
| SMA (200) | 2.8 | Sell |
| EMA (200) | 2.79 | Sell |

### Oscillators — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 26.77 | Buy |
| MACD (12,26,9) | -0.11 | Sell |
| Stochastic (14,3,3) | 10.02 | Buy |
| ADX (14) | 55.6 | Buy |
| Williams %R (14) | -100 | Buy |
| ATR (14) | 0.08 | High Volatility |
| ROC (12) | -14.04 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 42.47 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-06-11 | [Corporate Insolvency Resolution Process (CIRP)-Admission of application by Tribunal](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b41a72dd-695d-440c-8e68-76c2b2339460.pdf) |
| 2026-06-10 | [Corporate Insolvency Resolution Process (CIRP)-Admission of application by Tribunal](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e34571cc-b7fd-47e9-aa46-41a83e3db8e6.pdf) |
| 2026-05-30 | [Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Saturday 30Th May 2026 And Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d8332b93-d300-4402-a324-e26e389f50c0.pdf) |
| 2026-05-30 | [Appointment Of M/S. Jay Pandya & Associates (FRN: S2024GJ963300) Company Secretaries Ahmedabad As Secretarial Auditor Of The Company For The Financial Year 2025-26.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38ce0aab-4821-46f1-bf0b-53f54fbb7f2a.pdf) |
| 2026-05-30 | [Integrated Filing (Finance) For The Half Year And Year Ended On 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=235bac49-27cf-404d-97ec-07cca40b138f.pdf) |
| 2026-05-27 | [Board Meeting Intimation for Intimation For Rescheduling Of Board Meeting From 27Th May 2026 To 30Th May 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5cbc8b7-b63e-4e1b-8ce7-b64fca5709c0.pdf) |
| 2026-05-11 | [Board Meeting Intimation for Intimation For Rescheduling Of Board Meeting From 14Th May 2026 To 27Th May 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=808a0f14-43ef-42ed-8932-07403e5f0b73.pdf) |
| 2026-05-07 | [Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 14Th May 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f8f15be-bb83-4b27-a696-e25a66ace89f.pdf) |
| 2026-04-30 | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbd22248-58d3-4f3a-855c-39ca5fa35e89.pdf) |
| 2026-04-09 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c035498b-e5da-4818-9b91-4a4a56c9ef4b.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-05-30 | [Submission Of Audited Financial Results For The Half Year And Year Ended On 31St March 2026 Along With AuditorS Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=24b8c1a9-e68b-45a8-9596-babbef33a0ac.pdf) |
| 2025-10-10 | [Financial Result For Half Year Ended On 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=207cdd1b-a0fb-491b-a664-354d97f36b4b.pdf) |
| 2025-04-10 | [Submission Of Results For The Half Year And Year Ended On 31St March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2510ed3-683d-422b-9639-abc22142ba33.pdf) |
| 2025-03-03 | [Submission Of Unaudited Financial Results For The Half Year Ended On 30Th September 2024 Along With Limited Review Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f392a5e9-1dee-4c83-9de4-0c972fe34023.pdf) |
| 2024-07-12 | [Submission Of Revised Audited Financial Results For The Half Year And Year Ended On 31St March, 2024 Along With Auditor'S Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07a792ee-afc4-4cd8-9425-e30805ff701d.pdf) |
| 2024-05-27 | [Submission Of Audited Financial Results For The Half Year And Year Ended On 31St March, 2024 Along With Auditor'S Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80124ee3-ebb8-47c5-9590-f4e1fdfd0e39.pdf) |
| 2023-11-10 | [Submission Of Unaudited Financial Results For The Half Year Ended On 30Th September, 2023 Along With Limited Review Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0d8fc5e4-eb60-4fcf-a212-77981130b087.pdf) |
| 2023-05-25 | [Submission Of Audited Financial Results For The Half Year And Financial Year Ended On 31St March, 2023 Along With Auditor'S Report And Declaration](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=593ac39e-fc43-448b-92bb-6758155b4abe.pdf) |
| 2022-11-08 | [Submission Of Revised Unaudited Financial Results For The Half Year Ended On 30Th September, 2022 Along With Limited Review Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b8bae0e-9558-44e4-9b7e-e925091d39c5.pdf) |
| 2022-11-07 | [Submission Of Unaudited Financial Results For The Half Year Ended On 30Th September, 2022 Along With Limited Review Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b014287-344c-4349-b6c1-567e80af06c2.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Board meeting rescheduled from 14 May 2026 to 27 May 2026 to consider audited FY2026 results. | [Board Meeting Intimation for Intimation For Rescheduling Of Board Meeting From 14Th May, 2026 To 27Th May, 2026 9h - Board meeting rescheduled from 14 May 2026 to 27 May 2026 to consider audited FY2026 results.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/808a0f14-43ef-42ed-8932-07403e5f0b73.pdf) |
| 7 May - Board meeting on 14 May 2026 to approve audited half-year and year-end results for 31 March 2026. | [Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, 14Th May, 2026 7 May - Board meeting on 14 May 2026 to approve audited half-year and year-end results for 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4f8f15be-bb83-4b27-a696-e25a66ace89f.pdf) |
| 6 Jan - Submitted RTA certificate under Reg 74(5) for quarter ended 31 Dec 2025 (EVOQ, 543500) | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Jan - Submitted RTA certificate under Reg 74(5) for quarter ended 31 Dec 2025 (EVOQ, 543500)](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3e291b5c-e5e3-4d3f-b1a5-6f24f2ffc7b1.pdf) |
| 30 Mar - Trading window closed from 1 April 2026 until 48 hours after audited results for half-year/year ended 31 March 2026. | [Closure of Trading Window 30 Mar - Trading window closed from 1 April 2026 until 48 hours after audited results for half-year/year ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/62642cb7-5e79-414f-b63d-286602944754.pdf) |
| 30 Apr - Evoq Remedies confirms it is not a Large Corporate; outstanding borrowing nil as of 31 March 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Evoq Remedies confirms it is not a Large Corporate; outstanding borrowing nil as of 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cbd22248-58d3-4f3a-855c-39ca5fa35e89.pdf) |
| 30 Apr - Evoq Remedies confirms it is not a Large Corporate; outstanding borrowing nil as of 31 March 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Evoq Remedies confirms it is not a Large Corporate; outstanding borrowing nil as of 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/cbd22248-58d3-4f3a-855c-39ca5fa35e89.pdf) |
| 23 Jan - Re-appointment of Yashovardhan Chordia as CEO and Deputy MD; Board approved, subject to shareholder approval (23 Jan 2026). | [General Update 23 Jan - Re-appointment of Yashovardhan Chordia as CEO and Deputy MD; Board approved, subject to shareholder approval (23 Jan 2026).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/25cbff53-10bb-4a3c-9605-3945b43a9355.pdf) |
| 22 Jan - Newspaper Publication - Financial Results for the quarter ended 31st December 2025 | [Announcement under Regulation 30 (LODR)-Newspaper Publication 22 Jan - Newspaper Publication - Financial Results for the quarter ended 31st December 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5127b1fe-4da8-4cd0-9d26-130262db8f2a.pdf) |
| 21 Jan - Re-appointment of Yashovardhan Chordia as CEO & Dy. MD, 21 Apr 2026–20 Apr 2029, subject to shareholder approval. | [Announcement under Regulation 30 (LODR)-Change in Management 21 Jan - Re-appointment of Yashovardhan Chordia as CEO & Dy. MD, 21 Apr 2026–20 Apr 2029, subject to shareholder approval.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f17b47c0-8e13-48d9-bb51-d6b44f529eca.pdf) |
| 10 Oct 2025 - H1 FY2026 results; auditor flagged SEBI probe, Rs9.21Cr preferential show-cause; advances ₹1,250.87L, GST ₹655.03L, related loans ₹668.86L. | [Integrated Filling (Finance) 10 Oct 2025 - H1 FY2026 results; auditor flagged SEBI probe, Rs9.21Cr preferential show-cause; advances ₹1,250.87L, GST ₹655.03L, related loans ₹668.86L.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b3d9d9fb-ccf0-4217-8694-27675d7a6e43.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/498bb74a-a4da-4867-a2b5-bed9b1b75f12.pdf) |
| Oct 2023 | [Concall - Oct 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0f2e60c5-9254-4bdf-9395-31d934858899.pdf) |
| Oct 2022 | [Concall - Oct 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/06925f89-a358-4e5d-91fe-3a64f8655715.pdf) |
| Oct 2021 | [Concall - Oct 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/80acfbeb-ec9f-46d9-890f-d03e61472422.pdf) |
| Oct 2020 | [Concall - Oct 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/555c3593-57d7-4016-a1fc-6c4a9fec28df.pdf) |
| Oct 2019 | [Concall - Oct 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/427b51af-2692-4c17-9dbf-16f630ab9eee.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c7cf24fa-f92c-4343-8185-47c8d11105b3.pdf) |
| Nov 2018 | [Concall - Nov 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/11/23228cfc-e419-4f8f-923c-c048b8f4e5e0.pdf) |
| May 2019 | [Concall - May 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/069b6cfd-7777-443f-97ab-3c24c7c06f4e.pdf) |
| Jun 2020 | [Concall - Jun 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b6d4a1b5-ab49-478d-add9-0173c9c069fe.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d0be1625-c124-4c22-8b99-24179632f865.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5ed8e5e8-066e-42c9-b060-18d1de0967c1.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3a22a96a-a7c2-4e1b-827a-36b131dc0581.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f9c026de-7600-45ba-9447-ca0b6f73a6fe.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/086d437c-fa09-4e48-8daa-a7a2a1b09155.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dddb6290-d9c5-466a-b76e-e6b7597d3cc7.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/543500/75543543500.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/517522/73034517522.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/517522/68679517522.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/517522/5175220320.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:17:27.720Z.